top of page

New safer and shorter drug-resistant TB treatment must be scaled up

Médecins Sans Frontières (MSF) calls on governments and donors to speed up access to new, shorter, safer and more effective treatments for drug-resistant tuberculosis (DR-TB). MSF joined the World Health Organization (WHO) and other organisations in a ‘Call to Action’ ahead of World TB Day. MSF also urges the US-based diagnostics corporation Cepheid to drop the price of the critical GeneXpert tests, and for governments to scale up access to diagnostic test, to ensure that people with DR-TB can be diagnosed in time to access the shorter and safer treatment regimens. Read more here.

20 views0 comments

Recent Posts

See All
bottom of page